NEOSTIGMINE METHYLSULFATE
- Product NDC
- 55150-348
- 11-digit product format
- 551500348
- Labeler code
- 55150
- Product ID
- 55150-348_84d4656a-c5f6-4a93-ae5b-bf77b1b6ec36
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- NEOSTIGMINE METHYLSULFATE
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- Eugia US LLC
- Application
- ANDA213244
- Marketing category
- ANDA
- Marketing start
- 2023-11-02
- Substance
- NEOSTIGMINE METHYLSULFATE
- Active strength
- .5 mg/mL
- Pharmacologic classes
- Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A213244-001 | NEOSTIGMINE METHYLSULFATE | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | 2023-11-02 | ||
| A213244-002 | NEOSTIGMINE METHYLSULFATE | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | 2023-11-02 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A213244-001 | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | 2023-11-02 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A213244-002 | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | 2023-11-02 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213244-001 | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | 2023-11-02 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213244-002 | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | 2023-11-02 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A213244-001 | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | 2023-11-02 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A213244-002 | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | 2023-11-02 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213244-001 | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | 2023-11-02 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213244-002 | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | 2023-11-02 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A213244-001 | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | 2023-11-02 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A213244-002 | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | 2023-11-02 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A213244-001 | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | 2023-11-02 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A213244-002 | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | 2023-11-02 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A213244-001 | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | 2023-11-02 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A213244-002 | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | 2023-11-02 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A213244-001 | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | 2023-11-02 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A213244-002 | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | 2023-11-02 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A213244-001 | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | 2023-11-02 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A213244-002 | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | 2023-11-02 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A213244-001 | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | 2023-11-02 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A213244-002 | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | 2023-11-02 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A213244-001 | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | 2023-11-02 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A213244-002 | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | 2023-11-02 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A213244-001 | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | 2023-11-02 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A213244-002 | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | 2023-11-02 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A213244-001 | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | 2023-11-02 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A213244-002 | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | 2023-11-02 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A213244-001 | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | AP | 2023-11-02 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | A213244-002 | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2023-11-02 | 8072bd15b7f6… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A213244-001 | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | AP | 2023-11-02 | 6a51e52b5d6a… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A213244-002 | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2023-11-02 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | A213244-001 | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | AP | 2023-11-02 | 1c564ffb4f44… | |
| 2024-02-18 07:12 UTC | 2024-02 | A213244-002 | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2023-11-02 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | A213244-001 | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | AP | 2023-11-02 | ea1830bbd6c7… | |
| 2023-12-20 04:57 UTC | 2023-12 | A213244-002 | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2023-11-02 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A213244-001 | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | AP | 2023-11-02 | a72a2bbeb626… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A213244-002 | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2023-11-02 | a72a2bbeb626… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A213244-001 | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | 2023-11-02 | a50c72e98297… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A213244-002 | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | 2023-11-02 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2024-05-31 18:47 UTC | 2024-05 | A213244-001 | AP | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A213244-002 | AP | 1 | 8072bd15b7f6… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A213244-001 | AP | 1 | 6a51e52b5d6a… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A213244-002 | AP | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A213244-001 | AP | 1 | 1c564ffb4f44… |
| 2024-02-18 07:12 UTC | 2024-02 | A213244-002 | AP | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A213244-001 | AP | 1 | ea1830bbd6c7… |
| 2023-12-20 04:57 UTC | 2023-12 | A213244-002 | AP | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A213244-001 | AP | 1 | a72a2bbeb626… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A213244-002 | AP | 1 | a72a2bbeb626… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- NEOSTIGMINE METHYLSULFATE
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| NEOSTIGMINE METHYLSULFATE | .5 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 98IMH7M386 | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| c5729883-88d7-40fe-8fe4-fe39204ccb30 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| f58f10d3-5fa9-4c2e-9a6e-77029e9ed80b | Product name | 1 | 20231002 |
| 6c2b16d0-96e9-444e-98c5-9883cd6eb72d | Product name | 2 | 20230316 |
| 6bd95106-a412-1dad-b9cc-4cb74bfb27ce | Product name | 2 | 20230315 |
| ad279e69-d021-f6bd-1150-2b55f23832d5 | Product name | 9 | 20211014 |
| 48747306-602a-42cc-957b-5b0c69158eee | Product name | 1 | 20180604 |
| d5e51f11-ad28-caa4-4b49-4143974782ad | Product name | 1 | 20150831 |
| 290f523a-f9db-9774-b5a9-e1f908ac1782 | Product name | 1 | 20150828 |
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
| c6b65c52-69c7-df49-550a-a50c137f6218 | Product name | 1 | 20140508 |
| db5ebcdb-b6ae-21cd-4dc5-76cd84b5578b | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 55150-348-01 | NEOSTIGMINE METHYLSULFATE | 10 mL in 1 VIAL, MULTI-DOSE | INJECTION | 10 | 2 | |
| 55150-348-10 | NEOSTIGMINE METHYLSULFATE | 10 in 1 CARTON | INJECTION | 10 | 2 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| NEOSTIGMINE METHYLSULFATE | NEOSTIGMINE METHYLSULFATE | Eugia US LLC | c5729883-88d7-40fe-8fe4-fe39204ccb30 | 2024-08-29 | Warnings, Adverse reactions | 213244 ANDA213244 55150-348 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 311935 | neostigmine methylsulfate 0.5 MG/ML Injectable Solution | PSN | c5729883-88d7-40fe-8fe4-fe39204ccb30 | 2 |
| 311936 | neostigmine methylsulfate 1 MG/ML Injectable Solution | PSN | c5729883-88d7-40fe-8fe4-fe39204ccb30 | 2 |
| 311935 | neostigmine methylsulfate 0.5 MG/ML Injectable Solution | SCD | c5729883-88d7-40fe-8fe4-fe39204ccb30 | 2 |
| 311936 | neostigmine methylsulfate 1 MG/ML Injectable Solution | SCD | c5729883-88d7-40fe-8fe4-fe39204ccb30 | 2 |
| 311935 | neostigmine methylsulfate 0.5 MG/ML Injectable Solution | SY | c5729883-88d7-40fe-8fe4-fe39204ccb30 | 2 |
| 311936 | neostigmine methylsulfate 1 MG/ML Injectable Solution | SY | c5729883-88d7-40fe-8fe4-fe39204ccb30 | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 55150-348-01 | 55150034801 | 10 mL in 1 VIAL, MULTI-DOSE | 10 ml | Historical | |||
| 55150-348-10 | 55150034810 | 10 VIAL, MULTI-DOSE in 1 CARTON (55150-348-10) / 10 mL in 1 VIAL, MULTI-DOSE (55150-348-01) | 2023-11-02 | No | No | Current |